Review
Published on 09 Jun 2023
Potency assays and biomarkers for cell-based advanced therapy medicinal products
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1186224
- 20,192 views
- 27 citations
16 articles related to "Marketing Approval"
Articles
Original Research
Published on 03 May 2018
Exploring the Potential of Generative Adversarial Networks for Synthesizing Radiological Images of the Spine to be Used in In Silico Trials
in Biomechanics
Frontiers in Bioengineering and Biotechnology
doi 10.3389/fbioe.2018.00053
- 11,677 views
- 27 citations
Review
Published on 20 May 2020
The Use of Risperidone in Behavioral and Psychological Symptoms of Dementia: A Review of Pharmacology, Clinical Evidence, Regulatory Approvals, and Off-Label Use
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.00596
- 69,779 views
- 66 citations
Perspective
Published on 13 Jan 2022
The Current Status and Future Direction of Clinical Research in Japan From a Regulatory Perspective
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.816921
- 13,645 views
- 11 citations
Review
Published on 14 Aug 2012
Cell therapy medicinal product regulatory framework in Europe and its application for MSC-based therapy development
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2012.00253
- 19,837 views
- 93 citations
Review
Published on 21 Jun 2023
Regulation and safety measures for nanotechnology-based agri-products
in Genome Editing in Plants
Frontiers in Genome Editing
doi 10.3389/fgeed.2023.1200987
- 29,268 views
- 237 citations
Systematic Review
Published on 15 Oct 2021
Integrating Public Participation, Transparency and Accountability Into Governance of Marketing Authorisation for Genome Editing Products
in Politics of Technology
Frontiers in Political Science
doi 10.3389/fpos.2021.747838
- 12,160 views
- 15 citations
Original Research
Published on 16 Jun 2025
Promoting the development and approval of new traditional Chinese medicines in China: a pooled analysis of data from 2013 to 2024
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2025.1559703
- 3,833 views
- 2 citations
Review
Published on 23 May 2018
Industrializing Autologous Adoptive Immunotherapies: Manufacturing Advances and Challenges
in Gene and Cell Therapy
Frontiers in Medicine
doi 10.3389/fmed.2018.00150
- 42,908 views
- 115 citations
Perspective
Published on 15 Feb 2023
Chelating the valley of death: Deferoxamine’s path from bench to wound clinic
in Dermatology
Frontiers in Medicine
doi 10.3389/fmed.2023.1015711
- 5,938 views
- 20 citations
Original Research
Published on 06 Mar 2020
Marketing and Pricing Strategies of Blockbuster Drugs in the South Korean Market: A 15-Year Retrospective Cohort Study for Choline Alfoscerate
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2020.00232
- 9,079 views
- 8 citations
Systematic Review
Published on 15 Dec 2022
International oncology drug approvals for multiregional or single-country clinical trials: A systematic review
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.1084980
- 5,549 views
- 2 citations
Original Research
Published on 27 Jun 2024
Comparison of injective related reactions following ofatumumab and ocrelizumab in patients with multiple sclerosis: data from the European spontaneous reporting system
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1383910
- 4,513 views
- 6 citations
Brief Research Report
Published on 27 Aug 2020
AAV-Delivered Tulp1 Supplementation Therapy Targeting Photoreceptors Provides Minimal Benefit in Tulp1−/− Retinas
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2020.00891
- 5,640 views
- 9 citations
Original Research
Published on 09 Jan 2023
Efficacy and safety of bevacizumab biosimilar compared with reference bevacizumab in locally advanced and advanced non-small cell lung cancer patients: A retrospective study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1036906
- 4,846 views
- 10 citations
Original Research
Published on 08 Apr 2022
Neurological Adverse Events Associated With Esketamine: A Disproportionality Analysis for Signal Detection Leveraging the FDA Adverse Event Reporting System
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.849758
- 10,245 views
- 32 citations